Published in PLoS Genet on October 17, 2008
IRF8 mutations and human dendritic-cell immunodeficiency. N Engl J Med (2011) 3.29
The five Rs of glucocorticoid action during inflammation: ready, reinforce, repress, resolve, and restore. Trends Endocrinol Metab (2013) 1.21
Distinct transcriptional regulatory modules underlie STAT3's cell type-independent and cell type-specific functions. Nucleic Acids Res (2013) 1.21
ChIP-exo signal associated with DNA-binding motifs provides insight into the genomic binding of the glucocorticoid receptor and cooperating transcription factors. Genome Res (2015) 1.05
Interferon regulatory factor 8 regulates pathways for antigen presentation in myeloid cells and during tuberculosis. PLoS Genet (2011) 1.02
One hormone, two actions: anti- and pro-inflammatory effects of glucocorticoids. Neuroimmunomodulation (2014) 1.02
Proinflammatory actions of glucocorticoids: glucocorticoids and TNFα coregulate gene expression in vitro and in vivo. Endocrinology (2012) 1.00
Chronic exposure to exogenous glucocorticoids primes microglia to pro-inflammatory stimuli and induces NLRP3 mRNA in the hippocampus. Psychoneuroendocrinology (2013) 0.99
A pituitary-specific enhancer of the POMC gene with preferential activity in corticotrope cells. Mol Endocrinol (2010) 0.95
Stat3 Controls Tubulointerstitial Communication during CKD. J Am Soc Nephrol (2016) 0.84
Dynamic aberrant NF-κB spurs tumorigenesis: a new model encompassing the microenvironment. Cytokine Growth Factor Rev (2015) 0.83
myGRN: a database and visualisation system for the storage and analysis of developmental genetic regulatory networks. BMC Dev Biol (2009) 0.80
Glucocorticoid receptors: finding the middle ground. J Clin Invest (2017) 0.79
The Ets factor Etv1 interacts with Tpit protein for pituitary pro-opiomelanocortin (POMC) gene transcription. J Biol Chem (2011) 0.79
Glucocorticoid-independent modulation of GR activity: Implications for immunotherapy. Pharmacol Ther (2016) 0.78
Gene Expression Control by Glucocorticoid Receptors during Innate Immune Responses. Front Endocrinol (Lausanne) (2016) 0.76
MUC16 regulates TSPYL5 for lung cancer cell growth and chemoresistance by suppressing p53. Clin Cancer Res (2017) 0.75
Memory Training Program Decreases the Circulating Level of Cortisol and Pro-inflammatory Cytokines in Healthy Older Adults. Front Mol Neurosci (2017) 0.75
DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol (2003) 84.79
WebLogo: a sequence logo generator. Genome Res (2004) 59.58
Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome. Nat Genet (2007) 32.41
The nuclear receptor superfamily: the second decade. Cell (1995) 24.99
Genome-wide analysis of estrogen receptor binding sites. Nat Genet (2006) 18.63
Unbiased mapping of transcription factor binding sites along human chromosomes 21 and 22 points to widespread regulation of noncoding RNAs. Cell (2004) 16.15
Identifying DNA and protein patterns with statistically significant alignments of multiple sequences. Bioinformatics (1999) 14.36
Finding DNA regulatory motifs within unaligned noncoding sequences clustered by whole-genome mRNA quantitation. Nat Biotechnol (1998) 13.99
Model-based analysis of tiling-arrays for ChIP-chip. Proc Natl Acad Sci U S A (2006) 13.68
Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays. Proc Natl Acad Sci U S A (1998) 13.39
Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron. Nature (2004) 9.40
Innate immunity gone awry: linking microbial infections to chronic inflammation and cancer. Cell (2006) 5.97
Interleukin-6 dependent survival of multiple myeloma cells involves the Stat3-mediated induction of microRNA-21 through a highly conserved enhancer. Blood (2007) 5.14
Dual action of neutrophil gelatinase-associated lipocalin. J Am Soc Nephrol (2007) 4.99
Serum amyloid A, the major vertebrate acute-phase reactant. Eur J Biochem (1999) 4.94
Preprocessing of oligonucleotide array data. Nat Biotechnol (2004) 4.70
Lipocalin 2-deficient mice exhibit increased sensitivity to Escherichia coli infection but not to ischemia-reperfusion injury. Proc Natl Acad Sci U S A (2006) 3.85
Local-pooled-error test for identifying differentially expressed genes with a small number of replicated microarrays. Bioinformatics (2003) 3.75
Global position and recruitment of HATs and HDACs in the yeast genome. Mol Cell (2004) 3.74
Phylogeny of the serpin superfamily: implications of patterns of amino acid conservation for structure and function. Genome Res (2000) 3.55
Diagnosis and complications of Cushing's syndrome: a consensus statement. J Clin Endocrinol Metab (2003) 3.33
Determinants of cell- and gene-specific transcriptional regulation by the glucocorticoid receptor. PLoS Genet (2007) 3.24
Glucocorticoid receptor-dependent gene regulatory networks. PLoS Genet (2005) 2.19
Interferon-induced Mx proteins in antiviral host defense. Biochimie (2007) 2.00
Novel dimeric Nur77 signaling mechanism in endocrine and lymphoid cells. Mol Cell Biol (1997) 1.80
Heterodimerization between members of the Nur subfamily of orphan nuclear receptors as a novel mechanism for gene activation. Mol Cell Biol (1999) 1.68
Glucocorticoids suppress inflammation but spare innate immune responses in airway epithelium. Proc Am Thorac Soc (2004) 1.46
Endotoxin and the hypothalamo-pituitary-adrenal (HPA) axis. J Endotoxin Res (2003) 1.41
Tissue-specific autoregulation of the stat3 gene and its role in interleukin-6-induced survival signals in T cells. Mol Cell Biol (2001) 1.38
Bacterial colonization of nasal mucosa induces expression of siderocalin, an iron-sequestering component of innate immunity. Cell Microbiol (2005) 1.36
Role of Brg1 and HDAC2 in GR trans-repression of the pituitary POMC gene and misexpression in Cushing disease. Genes Dev (2006) 1.35
Glucocorticoids, chronic stress, and obesity. Prog Brain Res (2006) 1.33
Murine leukemia inhibitory factor gene disruption attenuates the hypothalamo-pituitary-adrenal axis stress response. Endocrinology (1998) 1.33
Antagonism between Nur77 and glucocorticoid receptor for control of transcription. Mol Cell Biol (1997) 1.31
Functional importance of Stat3 tetramerization in activation of the alpha 2-macroglobulin gene. J Biol Chem (2001) 1.25
Dimer-specific potentiation of NGFI-B (Nur77) transcriptional activity by the protein kinase A pathway and AF-1-dependent coactivator recruitment. Mol Cell Biol (2003) 1.24
Direct regulation of pituitary proopiomelanocortin by STAT3 provides a novel mechanism for immuno-neuroendocrine interfacing. J Clin Invest (2000) 1.23
STAT3-dependent enhanceosome assembly and disassembly: synergy with GR for full transcriptional increase of the alpha 2-macroglobulin gene. Genes Dev (2003) 1.22
Structural and functional genomics and evolutionary relationships in the cluster of genes encoding murine 2',5'-oligoadenylate synthetases. Genomics (2003) 1.19
Glucocorticoid regulation of the inflammatory response to injury. Acta Anaesthesiol Scand (2004) 1.19
Leukemia inhibitory factor (LIF) stimulates proopiomelanocortin (POMC) expression in a corticotroph cell line. Role of STAT pathway. J Clin Invest (1996) 1.14
Pituitary corticotroph SOCS-3: novel intracellular regulation of leukemia-inhibitory factor-mediated proopiomelanocortin gene expression and adrenocorticotropin secretion. Mol Endocrinol (1998) 1.11
Protein-protein interactions and transcriptional antagonism between the subfamily of NGFI-B/Nur77 orphan nuclear receptors and glucocorticoid receptor. Mol Endocrinol (2004) 1.09
Opposite regulation of pro-opiomelanocortin gene transcription by glucocorticoids and CRH. Mol Cell Endocrinol (1985) 1.08
Rb enhances p160/SRC coactivator-dependent activity of nuclear receptors and hormone responsiveness. J Biol Chem (2005) 1.07
Of old and new diseases: genetics of pituitary ACTH excess (Cushing) and deficiency. Clin Genet (2007) 0.93
A common pro-opiomelanocortin-binding element mediates leukemia inhibitory factor and corticotropin-releasing hormone transcriptional synergy. J Biol Chem (1997) 0.92
Different mechanisms for leukemia inhibitory factor-dependent activation of two proopiomelanocortin promoter regions. Endocrinology (2002) 0.88
Role of several mediators of inflammation on the mouse hypothalamo-pituitary-adrenal axis response during acute endotoxemia. Neuroimmunomodulation (1999) 0.83
Glucocorticoids inhibit the growth of AtT-20 mouse pituitary tumor cells. Mol Cell Endocrinol (1984) 0.79
Reversal of glucocorticoids-dependent proopiomelanocortin gene inhibition by leukemia inhibitory factor. Endocrinology (2006) 0.77
Human and mouse TPIT gene mutations cause early onset pituitary ACTH deficiency. Genes Dev (2003) 1.93
Pitx3 is required for motor activity and for survival of a subset of midbrain dopaminergic neurons. Development (2003) 1.90
Formation and differentiation of multiple mesenchymal lineages during lung development is regulated by beta-catenin signaling. PLoS One (2008) 1.63
Tpit determines alternate fates during pituitary cell differentiation. Genes Dev (2003) 1.48
Pitx2 is required at multiple stages of pituitary organogenesis: pituitary primordium formation and cell specification. Development (2002) 1.45
Pitx1 and Pitx2 are required for development of hindlimb buds. Development (2003) 1.43
PITX genes are required for cell survival and Lhx3 activation. Mol Endocrinol (2005) 1.35
Role of Brg1 and HDAC2 in GR trans-repression of the pituitary POMC gene and misexpression in Cushing disease. Genes Dev (2006) 1.35
Distinct developmental roles of cell cycle inhibitors p57Kip2 and p27Kip1 distinguish pituitary progenitor cell cycle exit from cell cycle reentry of differentiated cells. Mol Cell Biol (2009) 1.35
The Stat3/GR interaction code: predictive value of direct/indirect DNA recruitment for transcription outcome. Mol Cell (2012) 1.30
Congenital isolated adrenocorticotropin deficiency: an underestimated cause of neonatal death, explained by TPIT gene mutations. J Clin Endocrinol Metab (2004) 1.29
Dimer-specific potentiation of NGFI-B (Nur77) transcriptional activity by the protein kinase A pathway and AF-1-dependent coactivator recruitment. Mol Cell Biol (2003) 1.24
Characterization of pancreatic transcription factor Pdx-1 binding sites using promoter microarray and serial analysis of chromatin occupancy. J Biol Chem (2007) 1.21
The selector gene Pax7 dictates alternate pituitary cell fates through its pioneer action on chromatin remodeling. Genes Dev (2012) 1.16
TIF1beta/KAP-1 is a coactivator of the orphan nuclear receptor NGFI-B/Nur77. J Biol Chem (2009) 1.14
Protein-protein interactions and transcriptional antagonism between the subfamily of NGFI-B/Nur77 orphan nuclear receptors and glucocorticoid receptor. Mol Endocrinol (2004) 1.09
Rb enhances p160/SRC coactivator-dependent activity of nuclear receptors and hormone responsiveness. J Biol Chem (2005) 1.07
Divergent transcriptional activities determine limb identity. Nat Commun (2010) 1.07
Sequential expression and redundancy of Pitx2 and Pitx3 genes during muscle development. Dev Biol (2007) 1.05
Related pituitary cell lineages develop into interdigitated 3D cell networks. Proc Natl Acad Sci U S A (2011) 1.04
A tridimensional view of pituitary development and function. Trends Endocrinol Metab (2012) 1.02
Tpit-independent function of NeuroD1(BETA2) in pituitary corticotroph differentiation. Mol Endocrinol (2004) 0.99
The transcription factor Pitx3 is expressed selectively in midbrain dopaminergic neurons susceptible to neurodegenerative stress. J Neurochem (2013) 0.96
A pituitary-specific enhancer of the POMC gene with preferential activity in corticotrope cells. Mol Endocrinol (2010) 0.95
Mesenchymal patterning by Hoxa2 requires blocking Fgf-dependent activation of Ptx1. Development (2003) 0.95
Deletion of the Pitx1 genomic locus affects mandibular tooth morphogenesis and expression of the Barx1 and Tbx1 genes. Dev Biol (2007) 0.95
Developmental dependence on NurRE and EboxNeuro for expression of pituitary proopiomelanocortin. Mol Endocrinol (2008) 0.94
Low estriol levels in the maternal triple-marker screen as a predictor of isolated adrenocorticotropic hormone deficiency caused by a new mutation in the TPIT gene. Pediatrics (2006) 0.94
Retinoblastoma and the related pocket protein p107 act as coactivators of NeuroD1 to enhance gene transcription. J Biol Chem (2005) 0.93
Repression by homeoprotein pitx1 of virus-induced interferon a promoters is mediated by physical interaction and trans repression of IRF3 and IRF7. Mol Cell Biol (2002) 0.93
Cooperation between cyclin E and p27(Kip1) in pituitary tumorigenesis. Mol Endocrinol (2010) 0.92
A muscle-specific promoter directs Pitx3 gene expression in skeletal muscle cells. J Biol Chem (2007) 0.92
Striatal neuroadaptation and rescue of locomotor deficit by L-dopa in aphakia mice, a model of Parkinson's disease. J Neurochem (2005) 0.90
The T-box factor Tpit recruits SRC/p160 co-activators and mediates hormone action. J Biol Chem (2003) 0.90
The TPIT gene mutation M86R associated with isolated adrenocorticotropin deficiency interferes with protein: protein interactions. J Clin Endocrinol Metab (2007) 0.89
Pitx2 defines alternate pathways acting through MyoD during limb and somitic myogenesis. Development (2010) 0.87
Pitx1 in vivo promoter activity and mechanisms of positive autoregulation. Neuroendocrinology (2003) 0.86
Bone morphogenic protein (Smad)-mediated repression of proopiomelanocortin transcription by interference with Pitx/Tpit activity. Mol Endocrinol (2005) 0.85
Pituitary homeobox 2 regulates adrenal4 binding protein/steroidogenic factor-1 gene transcription in the pituitary gonadotrope through interaction with the intronic enhancer. Mol Endocrinol (2008) 0.84
Severe cortisol deficiency associated with reversible growth hormone deficiency in two infants: what is the link? J Clin Endocrinol Metab (2011) 0.84
Tpit-/-NeuroD1-/- mice reveal novel aspects of corticotroph development. Endocr Res (2004) 0.81
Adult pituitary cell maintenance: lineage-specific contribution of self-duplication. Mol Endocrinol (2013) 0.80
Differential regulation of proopiomelanocortin and pituitary-restricted transcription factor (TPIT), a new marker of normal and adenomatous human corticotrophs. J Clin Endocrinol Metab (2003) 0.80
The Ets factor Etv1 interacts with Tpit protein for pituitary pro-opiomelanocortin (POMC) gene transcription. J Biol Chem (2011) 0.79
Autoimmunity: acquired versus inherited pituitary deficiency - same difference? Nat Rev Endocrinol (2011) 0.76
[Tpit mutations reveal a new model of pituitary differentiation and account for isolated ACTH deficiency]. Med Sci (Paris) (2004) 0.76
Récepteurs à la Provençale. EMBO workshop on the biology of nuclear receptors. EMBO Rep (2003) 0.75
Pituitary Homeobox 1 (Ptx1) Is Differentially Expressed during Pituitary Development. Endocrinology (1999) 0.75
The side population phenomenon enriches for designated adrenocortical progenitor cells in mice. J Endocrinol (2012) 0.75